Scheessele William John — SEC Form 4 filings
SEC reporting owner CIK 1879378. 2 Form 4 filings on record with FilingPulse; latest filed 2025-04-15.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2025-01-23 to 2025-04-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 6,493 shares, $9,999 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: purchase of 6,493 shares @ $1.54 ($9,999) in Humacyte, Inc., filed 2025-04-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Humacyte, Inc. (HUMA) | Chief Commercial Officer | 2 | 1 leg · 6,493 sh · $9,999 | — | 1 |
Form 4 filings — Scheessele William John
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-04-15 | 4 | Humacyte, Inc. (HUMA) | Purchase (P): 6,493 @ $1.54 | EDGAR |
| 2025-01-23 | 4 | Humacyte, Inc. (HUMA) | Grant/award (A): 283,101 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1879378 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →